TMBIM6 antagonist-1
TMBIM6 antagonist-1, a potential TMBIM6 antagonist, prevents TMBIM6 binding to mTORC2, decreases mTORC2 activity, and also regulates TMBIM6-leaky Ca2+[1].
Product Specifications
CAS Number
123134-61-2
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
MTOR
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tmbim6-antagonist-1.html
Purity
98.92
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=CC=C1N)/C=C/C2=CC=CC([N+]([O-])=O)=C2
Molecular Formula
C15H12N2O3
Molecular Weight
268.27
Precautions
H302, H315, H319, H335
References & Citations
[1]Hyun-Kyoung Kim, et al. TMBIM6/BI-1 contributes to cancer progression through assembly with mTORC2 and AKT activation. Nat Commun. 2020 Aug 11;11 (1) :4012.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400253-500 1x 500 µL
Cytokeratin, LMW (AE-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741224-500 1x 500 µL
HCG-beta (HCGb/54+ HCGb/459), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882313-500 1x 500 µL
Rb1 (Tumor Suppressor Protein) (RB1/2313R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 